出版应用/物种/样本/稀释 | 参考文献 |
---|
- 免疫细胞化学; 人类; 1:1000; 图 s10b
- 免疫印迹; 人类; 1:1000; 图 2a
| Frattini V, Pagnotta S, Tala -, Fan J, Russo M, Lee S, et al. A metabolic function of FGFR3-TACC3 gene fusions in cancer. Nature. 2018;553:222-227 pubmed 出版商
|
| Koole K, van Kempen P, Swartz J, Peeters T, van Diest P, Koole R, et al. Fibroblast growth factor receptor 3 protein is overexpressed in oral and oropharyngeal squamous cell carcinoma. Cancer Med. 2016;5:275-84 pubmed 出版商
|
| Park S, Nam S, Keam B, Kim T, Jeon Y, Lee S, et al. VEGF and Ki-67 Overexpression in Predicting Poor Overall Survival in Adenoid Cystic Carcinoma. Cancer Res Treat. 2016;48:518-26 pubmed 出版商
|
| Mansoor A, Akhter A, Pournazari P, Mahe E, Shariff S, Farooq F, et al. Protein Expression for Novel Prognostic Markers (Cyclins D1, D2, D3, B1, B2, ITGβ7, FGFR3, PAX5) Correlate With Previously Reported Gene Expression Profile Patterns in Plasma Cell Myeloma. Appl Immunohistochem Mol Morphol. 2015;23:327-33 pubmed 出版商
|
| Kossack N, Terwort N, Wistuba J, Ehmcke J, Schlatt S, Scholer H, et al. A combined approach facilitates the reliable detection of human spermatogonia in vitro. Hum Reprod. 2013;28:3012-25 pubmed 出版商
|
| Guo J, Grow E, Mlcochova H, Maher G, Lindskog C, Nie X, et al. The adult human testis transcriptional cell atlas. Cell Res. 2018;28:1141-1157 pubmed 出版商
|
| Best S, Harapas C, Kersbergen A, Rathi V, Asselin Labat M, Sutherland K. FGFR3-TACC3 is an oncogenic fusion protein in respiratory epithelium. Oncogene. 2018;37:6096-6104 pubmed 出版商
|
| Lee C, Moon S, Jeong J, Lee S, Lee M, Yoo S, et al. Kaempferol targeting on the fibroblast growth factor receptor 3-ribosomal S6 kinase 2 signaling axis prevents the development of rheumatoid arthritis. Cell Death Dis. 2018;9:401 pubmed 出版商
|
| Lehtinen B, Raita A, Kesseli J, Annala M, Nordfors K, Yli Harja O, et al. Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas. BMC Cancer. 2017;17:310 pubmed 出版商
|
| Guancial E, Werner L, Bellmunt J, Bamias A, Choueiri T, Ross R, et al. FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder. Cancer Med. 2014;3:835-44 pubmed 出版商
|
| Xie Z, Gunaratne J, Cheong L, Liu S, Koh T, Huang G, et al. Plasma membrane proteomics identifies biomarkers associated with MMSET overexpression in T(4;14) multiple myeloma. Oncotarget. 2013;4:1008-18 pubmed
|
| Herrera Abreu M, Pearson A, Campbell J, Shnyder S, Knowles M, Ashworth A, et al. Parallel RNA interference screens identify EGFR activation as an escape mechanism in FGFR3-mutant cancer. Cancer Discov. 2013;3:1058-71 pubmed 出版商
|
| Balbás Martínez C, Rodriguez Pinilla M, Casanova A, Dominguez O, Pisano D, Gomez G, et al. ARID1A alterations are associated with FGFR3-wild type, poor-prognosis, urothelial bladder tumors. PLoS ONE. 2013;8:e62483 pubmed 出版商
|
| Ishigami T, Hida Y, Matsudate Y, Murao K, Kubo Y. The involvement of fibroblast growth factor receptor signaling pathways in dermatofibroma and dermatofibrosarcoma protuberans. J Med Invest. 2013;60:106-13 pubmed
|
| von Kopylow K, Staege H, Schulze W, Will H, Kirchhoff C. Fibroblast growth factor receptor 3 is highly expressed in rarely dividing human type A spermatogonia. Histochem Cell Biol. 2012;138:759-72 pubmed 出版商
|
| Wilson T, Fridlyand J, Yan Y, Penuel E, Burton L, Chan E, et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature. 2012;487:505-9 pubmed 出版商
|
| Marshall M, Hinz T, Kono S, Singleton K, Bichon B, Ware K, et al. Fibroblast growth factor receptors are components of autocrine signaling networks in head and neck squamous cell carcinoma cells. Clin Cancer Res. 2011;17:5016-25 pubmed 出版商
|
| Ware K, Marshall M, Heasley L, Marek L, Hinz T, Hercule P, et al. Rapidly acquired resistance to EGFR tyrosine kinase inhibitors in NSCLC cell lines through de-repression of FGFR2 and FGFR3 expression. PLoS ONE. 2010;5:e14117 pubmed 出版商
|
| Zingone A, Cultraro C, Shin D, Bean C, Morse H, Janz S, et al. Ectopic expression of wild-type FGFR3 cooperates with MYC to accelerate development of B-cell lineage neoplasms. Leukemia. 2010;24:1171-8 pubmed 出版商
|
| Hida Y, Kubo Y, Nishio Y, Murakami S, Fukumoto D, Sayama K, et al. Malignant acanthosis nigricans with enhanced expression of fibroblast growth factor receptor 3. Acta Derm Venereol. 2009;89:435-7 pubmed 出版商
|
| Karlou M, Saetta A, Korkolopoulou P, Levidou G, Papanastasiou P, Boltetsou E, et al. Activation of extracellular regulated kinases (ERK1/2) predicts poor prognosis in urothelial bladder carcinoma and is not associated with B-Raf gene mutations. Pathology. 2009;41:327-34 pubmed 出版商
|
| Hida Y, Kubo Y, Arase S. Activation of fibroblast growth factor receptor 3 and oncogene-induced senescence in skin tumours. Br J Dermatol. 2009;160:1258-63 pubmed 出版商
|
| Dawson M, Opat S, Taouk Y, Donovan M, Zammit M, Monaghan K, et al. Clinical and immunohistochemical features associated with a response to bortezomib in patients with multiple myeloma. Clin Cancer Res. 2009;15:714-22 pubmed 出版商
|
| Larson A, Cook J. Fibroblast growth factor receptor 3 (FGFR3) expression in malignant lymphomas. Appl Immunohistochem Mol Morphol. 2008;16:322-5 pubmed 出版商
|
| Chang H, Stewart A, Qi X, Li Z, Yi Q, Trudel S. Immunohistochemistry accurately predicts FGFR3 aberrant expression and t(4;14) in multiple myeloma. Blood. 2005;106:353-5 pubmed
|